James Investment Research Inc. bought a new stake in Integer Holdings Corp (NYSE:ITGR) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 25,840 shares of the medical equipment provider’s stock, valued at approximately $2,143,000. James Investment Research Inc. owned 0.08% of Integer as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in ITGR. Xact Kapitalforvaltning AB lifted its position in Integer by 18.6% during the 1st quarter. Xact Kapitalforvaltning AB now owns 5,737 shares of the medical equipment provider’s stock worth $324,000 after acquiring an additional 900 shares during the period. United Services Automobile Association lifted its position in Integer by 15.6% during the 2nd quarter. United Services Automobile Association now owns 6,847 shares of the medical equipment provider’s stock worth $443,000 after acquiring an additional 922 shares during the period. Verition Fund Management LLC lifted its position in Integer by 27.4% during the 2nd quarter. Verition Fund Management LLC now owns 4,510 shares of the medical equipment provider’s stock worth $292,000 after acquiring an additional 971 shares during the period. Legal & General Group Plc lifted its position in Integer by 1.8% during the 2nd quarter. Legal & General Group Plc now owns 62,439 shares of the medical equipment provider’s stock worth $4,045,000 after acquiring an additional 1,090 shares during the period. Finally, Federated Investors Inc. PA lifted its position in Integer by 236.3% during the 2nd quarter. Federated Investors Inc. PA now owns 2,411 shares of the medical equipment provider’s stock worth $156,000 after acquiring an additional 1,694 shares during the period. 96.14% of the stock is owned by hedge funds and other institutional investors.
In other news, CFO Jeremy Friedman sold 6,326 shares of the firm’s stock in a transaction that occurred on Monday, August 6th. The stock was sold at an average price of $72.01, for a total value of $455,535.26. Following the completion of the sale, the chief financial officer now directly owns 8,366 shares of the company’s stock, valued at approximately $602,435.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William B. Summers, Jr. sold 26,661 shares of the firm’s stock in a transaction that occurred on Friday, September 7th. The shares were sold at an average price of $81.07, for a total value of $2,161,407.27. The disclosure for this sale can be found here. Insiders sold a total of 107,311 shares of company stock valued at $8,201,676 over the last three months. Insiders own 3.60% of the company’s stock.
ITGR opened at $74.47 on Thursday. The company has a quick ratio of 2.95, a current ratio of 3.80 and a debt-to-equity ratio of 1.64. The company has a market capitalization of $2.37 billion, a PE ratio of 21.50 and a beta of 0.84. Integer Holdings Corp has a 12 month low of $42.50 and a 12 month high of $84.20.
Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, August 2nd. The medical equipment provider reported $1.06 EPS for the quarter, beating the consensus estimate of $0.88 by $0.18. The business had revenue of $313.00 million during the quarter, compared to analysts’ expectations of $379.41 million. Integer had a return on equity of 12.60% and a net margin of 6.63%. The company’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same period last year, the firm earned $0.62 EPS. As a group, research analysts forecast that Integer Holdings Corp will post 3.57 EPS for the current fiscal year.
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products.
Recommended Story: Short Selling – Explanation For Shorting Stocks
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.